BDR and Its Commitment to Digitalization and Employee Training:
We are pleased to announce the official release of version 2.0 of our Adellgene® Triplet Repeat Calculator software, a very useful tool for the interpretation of results obtained with our Adellgene® kits.
BDR strengthens its commitment to quality with CE IVDR 748704
We are pleased to announce the official release of version 2.0 of our Adellgene® Triplet Repeat Calculator software, a very useful tool for the interpretation of results obtained with our Adellgene® kits.
New version of the Adellgene® Triplet Repeat Calculator Results Analysis Tool (v2.0)
We are pleased to announce the official release of version 2.0 of our Adellgene® Triplet Repeat Calculator software, a very useful tool for the interpretation of results obtained with our Adellgene® kits.
We are pleased to announce that our Colombian distributor, the company Annar Healthcare, has created a video in which Dr. Daniel Salgado gives a comprehensive overview of the fragment analysis technology, and its importance in the diagnosis of trinucleotide expansion disorders such as Huntington’s disease or Friedreich’s Ataxia.
Fondo Europeo de Desarrollo Regional (FEDER)
Blackhills Diagnostic Resources S.L.U. participates in the “PAIP” Programme, whose result is to favor the growth and consolidation of SMEs, improving their financing, technology and access to advanced support services. The main objective is to achieve a more competitive business network.
2nd Cycle of Experts in Human Molecular Genetics organised by Annar Health Technologies
On Monday 12 September, Carolina Orrite, Field Application Specialist at BDR, participated in the 2nd Cycle of Experts in Human Molecular Genetics organised by our distributor Annar Healthcare.
Metformin could be used to treat Huntington’s disease
Huntington’s disease (HD) is an inherited, degenerative disease caused by an expansion of the CAG triplet (cytosine, adenine and guanine) in the first exon of the HTT gene encoding the huntingtin protein. When these expansions are repeated 36 times or more, patients suffer neurodegeneration.
New European In Vitro Diagnostic Medical Devices Regulation
There are only 3 weeks left until the implementation of the new European Regulation on In Vitro Diagnostic Medical Devices, which aims to create a safer, more transparent, reliable and predictable environment for these products. For us as manufacturers, this new regulation is good news as, for the first time, the requirements
14th November – World Diabetes Day
Yesterday, the 14th of November, was the World Diabetes Day, celebrated on the day of the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922. This day has been commemorated since 1991, in response to growing concerns about the escalating health threat posed by diabetes.
July – Fragile Awareness Month
July is Fragile X Syndrome Awareness Month! In addition, yesterday we celebrated the Fragile X Awareness Day, and for this reason, we would like to share with you a Q&A section that we have prepared about our Fragile X Syndrome Kits of the Adellgene product line. Here are some of
BDR
CE-IVD
Company
Products
Clients
